Literature DB >> 1778720

Surgical treatment of advanced gastric cancer with metastasis in para-aortic lymph node.

Y Yonemura1, K Katayama, T Kamata, S Fushida, M Segawa, S Ooyama, K Miwa, I Miyazaki.   

Abstract

We have studied the incidence and prognosis of N4 node (para-aortic lymph node) metastases in gastric cancer in 434 patients who had been referred to our department for surgical treatment during the period between 1978 and 1988. N4 nodal involvement was found in 76 (17.5%) of 434 patients who had received a laparotomy with resection, and in 42 (10.5%) of 400 patients who had "curative" resection. When the surgeon assessed that the patients had metastasis in para-aortic lymph nodes, the para-aortic lymph nodes lying above and below the left renal vein were completely removed (R4 gastrectomy). During this period, 42 patients with N4 nodal involvement underwent "curative" resection by R4 gastrectomy. Their treatment results were compared with those of 32 patients who underwent subtotal or total gastrectomy (R2 or R3 gastrectomy) without resection of metastases of para-aortic lymph nodes ("palliative" resection). The operating time and the operative mortality rate were similar in both groups (R4 vs R2 or R3 gastrectomy). The patients who had undergone "curative" resection (R4 gastrectomy) had a significantly higher five-year survival rate than those who had received "palliative" resection. The R4 gastrectomy is a rational and useful surgical procedure for treating patients with N4 nodal involvement.

Entities:  

Mesh:

Year:  1991        PMID: 1778720

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  12 in total

1.  Study on the risk factors of lymphatic metastasis and the indications of less in vasive operations in early gastric cancer.

Authors:  Bo-Jian Jiang; Rong-Xun Sun; Hao Lin; You-Fu Gao
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

Review 2.  Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer.

Authors:  Zhen Wang; Jun-Qiang Chen; Yun-Fei Cao
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

3.  D2 vs D2 Plus Para-aortic Lymph Node Dissection for Advanced Gastric Cancer.

Authors:  Mehmet Mahir Ozmen; Baris Zulfikaroglu; Fusun Ozmen; Munevver Moran; Necdet Ozalp; Selda Seckin
Journal:  Turk J Surg       Date:  2020-12-08

4.  Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer.

Authors:  F Bataille; P Rümmele; W Dietmaier; D Gaag; F Klebl; A Reichle; P Wild; F Hofstädter; A Hartmann
Journal:  Mol Pathol       Date:  2003-10

5.  Gastric carcinoma in China: Current status and future perspectives (Review).

Authors:  Xiaodong Zhu; Jin Li
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

6.  Surgical results of performing R4 gastrectomy for gastric cancer located in the upper third of the stomach.

Authors:  Y Yonemura; M Segawa; H Matsumoto; K Tsugawa; I Ninomiya; L Fonseca; T Fujimura; K Sugiyama; K Miwa; I Miyazaki
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

7.  Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer.

Authors:  Y Yonemura; I Ninomiya; M Kaji; K Sugiyama; K Fujimura; T Sawa; K Katayama; S Tanaka; Y Hirono; K Miwa
Journal:  World J Surg       Date:  1995 May-Jun       Impact factor: 3.352

8.  Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer.

Authors:  Y Hirono; S Fushida; Y Yonemura; H Yamamoto; H Watanabe; A Raz
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

9.  Distant lymph node metastasis of early gastric cancer.

Authors:  H Isozaki; K Okajima; T Ichinona; K Fujii; E Nomura; N Izumi; T Ohyama
Journal:  Surg Today       Date:  1997       Impact factor: 2.540

10.  Questionnaire survey regarding the current status of super-extended lymph node dissection in Japan.

Authors:  Shinji Morita; Takeo Fukagawa; Hisataka Fujiwara; Hitoshi Katai
Journal:  World J Gastrointest Oncol       Date:  2016-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.